Silence Therapeutics PLC - ESG Rating & Company Profile powered by AI
If you work at Silence Therapeutics PLC and you wish to use your ESG rating, please get in touch. The dashboard contains a questions and answers section on Silence Therapeutics PLC. This assessment of Silence Therapeutics PLC uses intelligence from across the internet and also from available disclosures by Silence Therapeutics PLC.
Silence Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.1; made up of an environmental score of 0.0, social score of 0.0 and governance score of 3.2.
1.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1779 | Taisho Pharmaceutical Holdings Co Ltd | 1.2 | Low |
| 1779 | VBI Vaccines Inc | 1.2 | Low |
| 1810 | Silence Therapeutics PLC | 1.1 | Low |
| 1810 | Captor Capital Corp | 1.1 | Low |
| 1810 | Century Therapeutics Inc | 1.1 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Silence Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Silence Therapeutics PLC report the average age of the workforce?
Sign up for free to unlockDoes Silence Therapeutics PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Silence Therapeutics PLC offer flexible work?
Sign up for free to unlockDoes Silence Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Silence Therapeutics PLC conduct supply chain audits?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Silence Therapeutics PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose water use targets?
Sign up for free to unlockDoes Silence Therapeutics PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Silence Therapeutics PLC have a product recall in the last two years?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Silence Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Silence Therapeutics PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose parental leave metrics?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Silence Therapeutics PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Silence Therapeutics PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Silence Therapeutics PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose its waste policy?
Sign up for free to unlockDoes Silence Therapeutics PLC report according to TCFD requirements?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose energy use targets?
Sign up for free to unlockDoes Silence Therapeutics PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Silence Therapeutics PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Silence Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver. It designs short interfering RNA molecules to harness the body's natural mechanism of RNA interference, and degrading messenger RNA molecules that encode specific targeted disease-associated proteins in a cell. The company is developing various product candidates, including SLN360, which is Phase I clinical trials for the treatment of cardiovascular disease with high lipoprotein; SLN124 that is in Phase I clinical trials for the treatment of non-transfusion dependent thalassemia, and Phase I clinical trials for the treatment of myelodysplastic syndrome; and SLN124 for the treatment of polycythemia vera. It has collaboration agreements with AstraZeneca PLC to discover, develop, and commercialize small interfering RNA therapeutics for the treatment of cardiovascular, renal, metabolic, and respiratory diseases; and Mallinckrodt Pharma IP Trading DAC to develop and commercialize RNAi drug targets designed to silence the complement cascade in complement-mediated disorders. The company also has a collaboration with Hansoh Pharmaceutical Group Company Limited to develop siRNAs for three undisclosed targets leveraging Silence's mRNAi GOLD platform. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc is headquartered in London, the United Kingdom.